Skip to main content

Trinity College Dublin, The University of Dublin

Menu Search


Trinity College Dublin By using this website you consent to the use of cookies in accordance with the Trinity cookie policy. For more information on cookies see our cookie policy.

      
Profile Photo

Dr. Patrick Hayden

Clinical Senior Lecturer (Haematology)

 haydenp@tcd.ie

 


Sborov D.W., Fortuna G.G., Hayden P.J., Sequence not salvage, British Journal of Haematology, 204, (5), 2024, p1590 - 1592, p1590-1592 , Journal Article, PUBLISHED  DOI
Hwang A., Hayden P., Pawlyn C., McLornan D., Garderet L., The role of maintenance therapy following autologous stem cell transplantation in newly diagnosed multiple myeloma: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT, British Journal of Haematology, 204, (4), 2024, p1159 - 1175, p1159-1175 , Journal Article, PUBLISHED  DOI
Beksac M., Eikema D.-J., Koster L., Hulin C., Poire X., Hamladji R.-M., Gromek T., Bazarbachi A., Ozkurt Z.N., Pabst T., Ben Othman T., Finke J., Pirogova O., Wu D., Hayat A., Hilgendorf I., Tholouli E., de Wreede L.C., Schonland S., Garderet L., Drozd-Sokolowska J., Raj K., Hayden P.J., Yakoub-Agha I., McLornan D.P., In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT, Bone Marrow Transplantation, 59, (4), 2024, p526 - 533, p526-533 , Journal Article, PUBLISHED  DOI
Gurnari C., Koster L., Baaij L., Heiblig M., Yakoub-Agha I., Collin M., Passweg J., Bulabois C.E., Khan A., Loschi M., Carnevale-Schianca F., Crisa E., Caravelli D., Kuball J., Saraceni F., Olivieri A., Rambaldi A., Kulasekararaj A.G., Hayden P.J., Badoglio M., Onida F., Scheid C., Franceschini F., Mekinian A., Savic S., Voso M.T., Drozd-Sokolowska J., Snowden J.A., Raj K., Alexander T., Robin M., Greco R., McLornan D.P., Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT, Blood Advances, 8, (6), 2024, p1444 - 1448, p1444-1448 , Journal Article, PUBLISHED  DOI
Robin M., Gras L., Koster L., Gagelmann N., van Gorkom G., Ederr M., Itala-Remes M., Zuckerman T., Beguin Y., Schaap N., Drozd-Sokolowska J., Raj K., Hayden P.J., de Wreede L.C., Battipaglia G., Polverelli N., Czerw T., HernandezBoluda J.C., Kroger N., Yakoub-agha I., McLornan D.P., Early liver complications after allogeneic haematopoietic stem cell transplantation in patients with myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of the EBMT, British Journal of Haematology, 204, (2), 2024, p715 - 718, p715-718 , Journal Article, PUBLISHED  DOI
Rovo A., Gras L., Piepenbroek B., Kroger N., Reinhardt H.C., Radujkovic A., Blaise D., Kobbe G., Niityvuopio R., Platzbecker U., Sockel K., Hunault-Berger M., Cornelissen J.J., Forcade E., Bourhis J.H., Chalandon Y., Kinsella F., Nguyen-Quoc S., Maertens J., Elmaagacli A., Mordini N., Hayden P., Raj K., Drozd-Sokolowska J., de Wreede L.C., McLornan D.P., Robin M., Yakoub-Agha I., Onida F., Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS"a study of the CMWP of the EBMT, American Journal of Hematology, 99, (2), 2024, p203 - 215, p203-215 , Journal Article, PUBLISHED  DOI
Potter V., Gras L., Koster L., Kroger N., Sockel K., Ganser A., Finke J., Labussiere-Wallet H., Peffault de Latour R., Koc Y., Salmenniemi U., Smidstrup Friis L., Jindra P., Schroeder T., Tischer J., Arat M., Pascual Cascon M., de Wreede L.C., Hayden P., Raj K., Drozd-Sokolowska J., Scheid C., McLornan D.P., Robin M., Yakoub-Agha I., Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT, Bone Marrow Transplantation, 59, (2), 2024, p224 - 231, p224-231 , Journal Article, PUBLISHED  DOI
Onida F., Gras L., Ge J., Koster L., Hamladji R.-M., Byrne J., Avenoso D., Aljurf M., Robin M., Halaburda K., Passweg J., Salmenniemi U., Sengeloev H., Apperley J., Clark A., Remenyi P., Morozova E., Kinsella F., Lenhoff S., Ganser A., Wu K.L., Perez-Martinez A., Hayden P.J., Raj K., Drozd-Sokolowska J., OrtI G., de Lavallade H., Yakoub-Agha I., McLornan D.P., Chalandon Y., Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia: A retrospective analysis from the Chronic Malignancies Working Party of the EBMT, British Journal of Haematology, 2024, Journal Article, PUBLISHED  DOI
Orti G., Gras L., Koster L., Kulagin A., Byrne J., Apperley J.F., Halaburda K., Blau I.W., Clark A., Kroger N., Griskevicius L., Carlson K., Collin M., Bloor A., Raiola A.M., Blaise D., Aljurf M., Lopez-Corral L., Sakellari I., Beguin Y., Wrobel T., de Rosa L., de Lavallade H., Hayden P.J., McLornan D., Chalandon Y., Yakoub-Agha I., Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT), Transplantation and Cellular Therapy, 30, (1), 2024, p93.e1 - 93.e12, p93.e1-93.e12 , Journal Article, PUBLISHED  DOI
Robin M, de Wreede LC, Schroeder T, Stölzel F, Kröger N, Koster L, Platzbecker U, Finke J, Ganser A, Blaise D, Ciceri F, Maertens J, Labussière Wallet H, Wang J, Chevallier P, Passweg J, Cornelissen JJ, Nguyen S, Forcade E, Charbonnier A, Bonifazi F, Hayden P, McLornan DP, Yakoub-Agha I., Primary Cancer Matters in Therapy-related Myeloid Neoplasm Patients Receiving Allogeneic Hematopoietic Cell Transplantation: A Study From the Chronic Malignancies Working Party of the EBMT., Hemasphere, 7, (4), 2023, pe851 , Journal Article, PUBLISHED  DOI
  

Page 1 of 11